183
Participants
Start Date
April 26, 2021
Primary Completion Date
July 22, 2024
Study Completion Date
July 22, 2024
Esketamine
Esketamine will be self-administered as nasal spray.
SSRI/SNRI
Participants will continue to take SSRI/SNRI that is approved for use in depression in their country of participation; off-label use of any SSRI/SNRI is not permitted. The continuing SSRI/SNRI dosage may be optimized throughout the study, at the investigator's discretion and based on the summary of product characteristics (SmPC) (or local equivalent, if applicable). During this LTE study, investigators will be allowed to switch individual participant's SSRI/SNRI for tolerability issues.
Chang Gung Memorial Hospital, Taoyuan District
Changhua Christian Hospital, Changhua
Multiprofile Hospital for Active Treatment in Neurology and Psychiatry Sveti Naum, Sofia
Processus Kft, Budapest
Centre for Mental Health Prof.N.Shipkovenski EOOD, Sofia
Instituto de Neurociencias San Agustin, La Plata
C I A P Centro de investigacion y Asistencia en Psiquiatria, Rosario
Bugat Pal Korhaz, Gyöngyös
Anima, Alken
Fundacion Lennox, Córdoba
Hacettepe University Medical Faculty, Ankara
Mental Health Center - Rousse, Rousse
Cape Town Clinical Research Centre, Cape Town
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Medizinisches Versorgungszentrum LiO GmbH, Berlin
Praxis Dr. med. Kirsten Hahn, Berlin
Medical Services Prague S R O, Prague
Oberhavel Kliniken GmbH, Hennigsdorf
Institut Neuropsychiatricke pece, Prague
Somni Bene GmbH, Schwerin
Klinische Forschung Schwerin GmbH, Schwerin
Klinische Forschung Hamburg, Hamburg
University General Hospital of Rio Patras, Pátrai
Hospital Raja Permaisuri Bainun, Ipoh
A Shine S R O, Pilsen
Erenkoy Mental Health Hospital, Istanbul
Hospital Pengajar Universiti Putra Malaysia, Serdang
Klinikum Dortmund gGmbH, Dortmund
NeuropsychiatrieHK, s.r.o., Hradec Králové
Liv Hospital, Samsun
G Papanikolaou Hospital of Thessaloniki, Thessaloniki
University Malaya Medical Centre, Kuala Lumpur
Psychiatricka ambulance Saint Anne s.r.o., Brno
Psychiatricka ambulance, MUDr. Marta Holanova, Brno
Hospital Tuanku Jaafar, Seremban
Psychiatric Clinic 'Agios Charalampos', Heraklion
Universitätsklinikum Freiburg - Abteilung für Psychiatrie u. Psychotherapie mit Poliklinik, Freiburg im Breisgau
Danuvius Klinik Pfaffenhofen Fachklinik für Psychiatrie, Psychotherapie und Psychosomatik, Pfaffenhofen
FunDaMos, Buenos Aires
CEN Consultorios Especializados en Neurociencias, Córdoba
Instituto Medico DAMIC, Córdoba
Sanatorio Prof Leon S Morra S A, Córdoba
AD71 s.r.o., Prague
Mederon LTD at ARTES, Helsinki
Pharmakologisches Studienzentrum Chemnitz GmbH, Mittweida
Petz Aladar Megyei Oktato Korhaz, Győr
Mlynowamed Specjalistyczny Psychiatryczny Gabinet Lekarski Joanna Lazarczyk, Bialystok
Osrodek Badan Klinicznych CLINSANTE S C, Bydgoszcz
Uniwersyteckie Centrum Kliniczne, Gdansk
Centrum Badan Klinicznych PI House sp z o o, Gdansk
Centrum Medyczne Care Clinic Katowice, Katowice
Niepubliczny Zaklad Opieki Psychiatrycznej MENTIS, Leszno
Specjalistyczny Psychiatryczny Zespol Opieki Zdrowotnej w Lodzi Szpital im. J. Babinskiego, Lodz
SPZOZ CSK UM w Lodzi Klinika Zaburzen Afektywnych i Psychotycznych, Lodz
Osrodek Badan Klinicznych CLINSANTE S C, Torun
Gert Bosch Pretoria South Africa, Pretoria
Severance Hospital Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
Janssen-Cilag Ltd.
INDUSTRY